Virgin Orbit stock plummets after failure of its first UK rocket launch

Virgin Orbit stock plummets after failure of its first UK rocket launch


Cosmic Girl, a Virgin Boeing 747-400 aircraft sits on the tarmac with Virgin Orbit’s LauncherOne rocket attached to the wing, ahead of the first UK launch tonight, at Spaceport Cornwall at Newquay Airport in Newquay, Britain, January 9, 2023.

Henry Nicholls | Reuters

Virgin Orbit stock fell in trading on Monday evening, after the company confirmed that its first launch out of the United Kingdom failed to reach orbit.

Shares of Virgin Orbit fell as much as 30% in after-hours trading, from its previous close of $1.93 a share.

The company uses a modified 747 jet to send satellites into space, by dropping a rocket from under the aircraft’s wing mid-flight – a method known as air launch.

Virgin Orbit’s webcast showed its LauncherOne rocket released and fired its engine, with the company saying in a tweet that the rocket “successfully reached Earth orbit.” But about half an hour later, the company announced the launch had “an anomaly” and that the nine satellites onboard would not reach orbit.

Virgin Orbit is reviewing the launch data to identify the source of the failure, and acknowledged that it deleted the tweet about reaching orbit. The 747 jet and its crew safely returned and landed at Spaceport Cornwall in southwest England.

Sign up here to receive weekly editions of CNBC’s Investing in Space newsletter.

Monday’s mission was Virgin Orbit’s sixth to date, and its second launch failure.

The company conducted just two launches in 2022, short of the forecast for four to six missions that Virgin Orbit gave at the beginning of last year. At the end of the third quarter, Virgin Orbit had $71.2 million in cash on hand, and raised an additional $25 million from Richard Branson’s Virgin Group, an existing major shareholder, in the middle of the fourth quarter.



Source

Where the blockbuster weight loss drug market stands today — and what’s coming next
Business

Where the blockbuster weight loss drug market stands today — and what’s coming next

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied.  From fresh competition to new uses, the market is quickly vaulting into a new stage of […]

Read More
Just 5% of CRE companies have achieved their AI goals. Here’s why
Business

Just 5% of CRE companies have achieved their AI goals. Here’s why

Diminishing perspective of downtown London skyscrapers Chunyip Wong | Istock | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large […]

Read More
Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices
Business

Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices

A customer shops for Halloween candy at a Walmart Supercenter on October 16, 2024 in Austin, Texas.  Brandon Bell | Getty Images The scariest thing haunting Halloween this year isn’t a ghost, goblin or ghoul — it’s the price of chocolate. From Snickers to Reese’s to Twix, one of America’s favorite indulgences is getting more […]

Read More